We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cytovance Biologics Selected for GMP Manufacture of AM0010
News

Cytovance Biologics Selected for GMP Manufacture of AM0010

Cytovance Biologics Selected for GMP Manufacture of AM0010
News

Cytovance Biologics Selected for GMP Manufacture of AM0010

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cytovance Biologics Selected for GMP Manufacture of AM0010"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cytovance Biologics has announced successful completion of GMP manufacture of ARMO BioSciences’ lead product, AM0010, a PEGylated form of recombinant human interleukin-10 (IL-10).

“Cytovance is proud to have been an integral partner in the manufacture of AM0010 bulk drug substance and drug product,” states Darren Head, President and Chief Executive Officer of Cytovance Biologics. “Our team responded to the urgency to get this important drug to patients with advanced solid tumors.”

“Cytovance’s responsive and professional team enabled us to accelerate the time to clinic of AM0010 which is currently in a Phase 1 dose escalation study in patients with cancer,” said Peter Van Vlasselaer, Ph.D., President and Chief Executive Officer of ARMO. “We look forward to continuing our relationship with Cytovance as the manufacturer of product in support of the clinical development of AM0010.”

“Cytovance’s state-of-the-art facilities and staff are prepared to deliver the highest quality of manufacturing services for ARMO,” adds Darren Head.

Head continued, “We are delighted to work with ARMO. Their fast pace and rigorous scientific know-how are a good match for Cytovance’s sense of urgency and flexibility. Together, we can produce high quality material for patients quickly and efficiently in a cost-efficient manner.”

Advertisement